Company / Depreciation & Amortization
InspireMD, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$280.0M
FY2025
5-year range
$151.0K / $280.0M
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 4 consecutive years, from $151,000 in FY2021 to $280M in FY2025.
Based on SEC 10-K filings.
$280M in FY2025 with a 5-year CAGR of +346.4%.
Increased from $188M to $280M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +346.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- InspireMD, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +346.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 20.7% year-over-year.
- Lowest depreciation & amortization in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $280.0M | +20.7% |
| FY2024 | $232.0M | +23.4% |
| FY2023 | $188.0M | +116670.2% |
| FY2022 | $161.0K | +6.6% |
| FY2021 | $151.0K | -4.4% |
| FY2020 | $158.0K | +13.7% |
| FY2019 | $139.0K | -9.2% |
| FY2018 | $153.0K | +7.7% |
| FY2017 | $142.0K | -6.6% |
| FY2016 | $152.0K | -6.7% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026